JPMorgan Analyst Raises Price Target on UnitedHealth Despite Sector Challenges
UnitedHealth Group (UNH) shares remain under pressure, down 39% year-to-date as rising Medicare Advantage costs dent profitability. JPMorgan's top analyst Lisa Gill nonetheless lifted her price target to $418, citing management's corrective actions during recent meetings.
The healthcare insurer's outpatient service utilization has driven medical expenses beyond forecasts, prompting operational adjustments. Gill's revised valuation implies 36% upside potential, maintaining a Buy rating despite sector-wide margin compression.